Bispecific Antibody Product Deployment and Upgrade

Bispecific antibody product data primarily originates from preclinical study reports, clinical trial data, patent literature, academic papers, and

Data Characteristics for This Category

Bispecific antibody product data primarily originates from preclinical study reports, clinical trial data, patent literature, academic papers, and various bioinformatics databases. This data updates frequently, with new targets, structures, and indications continuously generating new information. Document structures typically include target information, antibody sequences (heavy and light chain variable region amino acid sequences), mechanism of action, pharmacokinetic (PK) data, pharmacodynamic (PD) data, safety data, manufacturing process information, and quality control standards. Fields cover CDR1, CDR2, CDR3 sequences, affinity constant (KD) (unit: nM), half-life (t1/2) (unit: hours), and dosage (mg/kg).

Constraints Imposed by These Characteristics on "Deployment and Upgrade"

High-frequency data updates require the knowledge base to have flexible incremental update mechanisms after deployment to ensure information timeliness. The specific nature of antibody sequence data, such as the need for precise CDR region matching, demands higher performance from text vectorization models and retrieval algorithms, requiring optimization for biological sequence features. Diverse document structures, ranging from structured database records to unstructured research reports, mean supporting multiple file formats for parsing, such as PDF, DOCX, and FASTA. Key fields must be accurately extracted. For example, extracting KD values requires recognizing numerical values and their units, then standardizing storage. The deployment environment must consider computational resources to handle large-scale sequence data processing and complex query computational demands. During upgrades, data model compatibility is crucial to prevent data loss or misalignment due to field changes.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
UPLOAD_FILE_MAX_SIZE500 MBPreclinical reports and trial data files can be large; this ensures full document uploads.
maxContext2000 charactersDescriptions of bispecific antibody mechanisms are often long; this ensures complete context.
PARSE_FILE_TIMEOUT_SECONDS600 secondsProcessing large PDFs or FASTA files with complex tables requires more time.
Chunk size800 charactersBalances semantic completeness with vectorization efficiency, avoiding excessive truncation of key information.
Recall countTop 8 entriesIncreases coverage of relevant information for complex queries, especially in sequence alignment scenarios.
Similarity threshold0.75High precision is required for biological sequences and pharmacological data, filtering out low-relevance results.

Three Common Mistakes

  1. After a knowledge base upgrade, specific fields like userId appear empty in some queries. This typically occurs because the new version's data model changed how user identity is stored or retrieved, causing existing query logic to fail mapping.
  2. Docker containers deployed in a Linux environment fail to start or run unstably. This might be due to insufficient host resources (CPU, memory) or compatibility issues between the Docker image and the system kernel version.
  3. The workflow canvas experiences significant lag when the number of nodes increases, with drag operations delayed by several seconds. This often indicates a frontend rendering performance bottleneck, potentially related to the current FastGPT version's workflow engine not being optimized for complex graph structures.

How to Verify Correct Configuration

  1. Upload a PDF file containing bispecific antibody sequences (e.g., FASTA format) and KD values from a preclinical report. Check if the knowledge base correctly parses and extracts CDR sequences and affinity constant, ensuring correct units.
  2. Simulate multiple concurrent user queries about the mechanism of action of bispecific antibodies for a specific target. Observe if the system response time is within an acceptable range and if the results include relevant patent or clinical trial information.
  3. Perform drag and edit operations on a workflow with many nodes. Evaluate the canvas responsiveness and confirm it meets expected fluidity, comparing it against the official demo version.

Note: The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.